Overview
- Bloom reported a stronger‑than‑expected second quarter on July 28 with about $1.065 billion in revenue, positive non‑GAAP EPS, roughly $226 million of operating cash flow, and raised 2026 revenue guidance to $3.9 billion–$4.2 billion.
- The company exits fiscal 2025 with an approximately $20 billion backlog and a broadened Brookfield financing framework that management says supports rapid deployments.
- Short‑seller Hunterbrook publicly questioned the quality of Bloom’s backlog, customer concentration and supply‑chain assumptions and Bloom has formally disputed those allegations.
- Permitting and project risks have emerged as concrete constraints, highlighted by New Mexico regulators rejecting the natural‑gas pipeline tied to Oracle’s Project Jupiter, a large planned customer deployment.
- Bloom’s rapid share‑price gain and high valuation have focused investor attention on concentration and governance, including congressional disclosures that Paul Pelosi bought multimillion‑dollar Bloom positions, which has amplified scrutiny.